Valproic Acid (sodium salt)

Valproic Acid (sodium salt)

CAT N°: 13033
Price:

From 55.00 46.75

Valproic acid is an analog of the natural fatty acid valeric acid that inhibits class I histone deacetylases (HDACs) with an IC50 value of approximately 2 mM.{17456} It decreases the number of axon branches in sensory neurons isolated from newborn rat dorsal root ganglia, an effect that is reversed by inositol-1,4,5-trisphosphate (1,4,5-IP3).{9786} In vivo, valproic acid inhibits amyloid-? deposition and neuritic plaque formation and decreases escape latency in Morris water maze, indicating improved memory performance, in the APP23 transgenic mouse model of Alzheimer’s disease.{17458} Valproic acid has anticonvulsant activity in the pentylenetetrazol seizure threshold test in mice (ED50 = 0.71 mmol/kg) but induces neurotoxicity when administered at doses greater than or equal to 1.2 mmol/kg.{42211} Formulations containing valproic acid have been used in the treatment of bipolar disorder and various seizure disorders.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 2-propyl-pentanoic acid, monosodium salt
  • Correlated keywords
    • APP-23 anti-convulsant 99-66-1
  • Product Overview:
    Valproic acid is an analog of the natural fatty acid valeric acid that inhibits class I histone deacetylases (HDACs) with an IC50 value of approximately 2 mM.{17456} It decreases the number of axon branches in sensory neurons isolated from newborn rat dorsal root ganglia, an effect that is reversed by inositol-1,4,5-trisphosphate (1,4,5-IP3).{9786} In vivo, valproic acid inhibits amyloid-? deposition and neuritic plaque formation and decreases escape latency in Morris water maze, indicating improved memory performance, in the APP23 transgenic mouse model of Alzheimer’s disease.{17458} Valproic acid has anticonvulsant activity in the pentylenetetrazol seizure threshold test in mice (ED50 = 0.71 mmol/kg) but induces neurotoxicity when administered at doses greater than or equal to 1.2 mmol/kg.{42211} Formulations containing valproic acid have been used in the treatment of bipolar disorder and various seizure disorders.

We also advise you